Picture of Almirall SA logo

ALM Almirall SA Share Price

0.000.00%
es flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Momentum

Relative Strength (%)
1m-8.36%
3m-12.23%
6m-24.12%
1yr-19.34%
Volume Change (%)
10d/3m-31.02%
Price vs... (%)
52w High-20.34%
50d MA-4.13%
200d MA-7.02%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)25.5
PEG Ratio (f)0.28
EPS Growth (f)1,039.2%
Dividend Yield (f)2.14%
Valuation (ttm)IndustryMarket
Price to Book Value1.15
Price to Tang. Book8.58
Price to Free Cashflown/a
Price to Sales1.88
EV to EBITDA14.25

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-0.26%
Return on Equity-2.77%
Operating Margin-0.59%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue€m855.34807.43827.2863.25894.52972.821,078.383.4%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+23.58+20.52-74.13-57.59n/an/a+67.4n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Almirall SA EPS forecast chart

Profile Summary

Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The Company's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The Company operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
January 1st, 1970
Public Since
April 19th, 2007
No. of Employees
1,904
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
es flag iconMadrid Stock Exchange
Shares in Issue
209,393,724

ALM Share Price Performance

Upcoming Events for ALM

Almirall SA Annual Shareholders Meeting

Q1 2024 Almirall SA Earnings Release

Half Year 2024 Almirall SA Earnings Release

Similar to ALM

Picture of 1nkemia IUCT SA logo

1nkemia IUCT SA

es flag iconMadrid Stock Exchange

Picture of Faes Farma SA logo

Faes Farma SA

es flag iconMadrid Stock Exchange

Picture of Grifols SA logo

Grifols SA

es flag iconMadrid Stock Exchange

Picture of Labiana Health SA logo

Labiana Health SA

es flag iconMadrid Stock Exchange

Picture of Laboratorio Reig Jofre SA logo

Laboratorio Reig Jofre SA

es flag iconMadrid Stock Exchange

FAQ